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Abstract
Background: There are many descriptions of the association of pica with iron deficiency in adults, but there are
few reports in which observations available at diagnosis of iron deficiency were analyzed using multivariable
techniques to identify significant predictors of pica. We sought to identify clinical and laboratory correlates of pica
in adults with iron deficiency or depletion using univariable and stepwise forward logistic regression analyses.
Methods: We reviewed charts of 262 non-pregnant adult outpatients (ages ≥18 y) who required treatment with
intravenous iron dextran. We tabulated their sex, age, race/ethnicity, body mass index, symptoms and causes of
iron deficiency or depletion, serum iron and complete blood count measures, and other conditions at diagnosis
before intravenous iron dextran was administered. We excluded patients with serum creatinine >133 μmol/L or
disorders that could affect erythrocyte or iron measures. Iron deficiency was defined as both SF <45 pmol/L and TS
<10%. Iron depletion was defined as serum ferritin (SF) <112 pmol/L. We performed univariable comparisons and
stepwise forward logistic regression analyses to identify significant correlates of pica.
Results: There were 230 women (184 white, 46 black; ages 19-91 y) and 32 men (31 white, 1 black; ages 24-81 y).
118 patients (45.0%) reported pica; of these, 87.3% reported ice pica (pagophagia). In univariable analyses, patients
with pica had lower mean age, black race/ethnicity, and higher prevalences of cardiopulmonary and epithelial
manifestations. The prevalence of iron deficiency, with or without anemia, did not differ significantly between
patients with and without pica reports. Mean hemoglobin and mean corpuscular volume (MCV) were lower and
mean red blood cell distribution width (RDW) and platelet count were higher in patients with pica. Thrombocytosis
occurred only in women and was more prevalent in those with pica (20.4% vs. 8.3%; p = 0.0050). Mean total iron-
binding capacity was higher and mean serum ferritin was lower in patients with pica. Nineteen patients developed
a second episode of iron deficiency or depletion; concordance of recurrent pica (or absence of pica) was 95%.
Predictors of pica in logistic regression analyses were age and MCV (negative associations; p = 0.0250 and 0.0018,
respectively) and RDW and platelet count (positive associations; p = 0.0009 and 0.02215, respectively); the odds
ratios of these predictors were low.
Conclusions: In non-pregnant adult patients with iron deficiency or depletion, lower age is a significant predictor
of pica. Patients with pica have lower MCV, higher RDW, and higher platelet counts than patients without pica.
Background
Pica is the daily compulsive eating of food or non-food
items not part of one’s habitual diet or preferences. Pica
is a distinctive but poorly understood accompaniment of
iron deficiency or depletion in some adults, although
most pica items contain little or no iron. Hippocrates
wrote that “a craving to eat earth” was associated with
“corruption of the blood” [1,2]. In the early 15
th C, de
Cervantes reported a history in which “women that by
caprice eat soil, plaster, coal and other disgusting sub-
stances” [3]. Physicians of the 19
th Cr e p o r t e dt h a tp e r -
sons with chlorosis (predominantly women) had
“various forms of pica or morbid appetite, as for pickles,
magnesia, cinders, &c” [4], or “capricious appetite” [5].
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ciency or depletion typically ingest only one or a few
substances in a compulsive manner. Pica items are
diverse, and vary according to race/ethnicity, culture,
and geographic location [1,6-10].
Many reports describe substances that patients with
iron deficiency consumed in a compulsive manner, and
effects of treatment of iron deficiency on pica [1,4,6-12].
There are few reports in which observations available at
diagnosis of iron deficiency were evaluated using multi-
variable analyses to identify possible significant differ-
ences between persons who did and did not develop
pica. In a case-control study from France, a logistic
regression model demonstrated that iron deficiency and
being non-European were significant independent pre-
dictors of pica [9]. Significant race/ethnicity differences
i nt h ep r e v a l e n c eo fp i c ah a v ea l s ob e e nr e p o r t e di n
other iron deficiency case series [8,11,13-15]. Among
iron-deficient adults of the same race/ethnicity, some
develop pica and others do not [8,11,13-15]. These
observations suggest that heritable traits could contri-
bute to pica susceptibility in adults with iron deficiency.
It is generally accepted that some patients who devel-
oped pica with an initial episode of iron deficiency will
develop pica during subsequent episodes of iron defi-
ciency [13,16,17]. Regardless, we were unable to identify
reports in which the concordance of pica or no pica
with successive episodes of iron deficiency in the same
series of patients was quantified. High concordance also
suggests that heritable factors increase the likelihood
that pica would accompany iron deficiency.
We sought to identify clinical and laboratory corre-
lates of pica in 262 consecutive non-pregnant adult out-
patients at diagnosis of iron deficiency or depletion.
These patients were referred because they needed treat-
ment with intravenous iron. In each case, we tabulated
sex, age, race/ethnicity, body mass index, symptoms
attributed to iron deficiency or depletion, causes of iron
deficiency or depletion, serum iron and complete blood
count (CBC) measures, and other medical conditions at
diagnosis of iron deficiency before intravenous iron was
administered. We performed univariable and multivari-
able analyses to identify significant positive and negative
predictors of pica. We compared and contrasted our
results with previous reports of pica associated with iron
deficiency, and discuss abnormalities that could account
for pica in iron deficiency and depletion.
Methods
Patient selection
The performance of this study was approved by the
Institutional Review Board of Brookwood Medical Cen-
ter. We performed retrospective reviews of the charts of
all adult outpatients (≥18 years of age) who were treated
with intravenous iron dextran in a single referral hema-
tology and medical oncology practice during the interval
2002-2009. Cases were identified by computerized and
manual searches of practice medical and billing records
for International Classification of Diseases (ICD) code
280.0 (iron deficiency), ICD code 307.52 (pica), and pro-
cedure codes corresponding to administration of intra-
venous iron dextran. Each patient was evaluated by
either JCB or LFB. Each patient was treated with intra-
venous iron dextran (Imferon® or INFed®; Watson
Pharma, Inc., Morristown, NJ) because he/she could not
tolerate oral iron supplements; his/her iron deficiency or
depletion did not resolve with trials of oral iron supple-
mentation; or he/she had anemia or other manifestation
(s) too severe to manage with oral iron supplements [8].
We excluded patients who were pregnant; were hospi-
talized; had serum creatinine >133 μmol/L; had been
treated with erythrocyte transfusion to alleviate anemia;
had types of acquired anemia other than that due to
iron deficiency or depletion; had erythrocytosis, poly-
cythemia, or other bone marrow disorder not in remis-
sion; were receiving anti-cancer chemotherapy or
radiation therapy; or had hyperferritinemia due to acute
phase reaction, chronic inflammation, liver injury, malig-
nancy, or other cause.
Laboratory techniques
CBCs were performed using Cell-Dyn® 1800 or 1500
automated blood counters (Abbott Laboratories, Chicago,
IL). Reference ranges for red blood cells (RBC), mean
corpuscular volume (MCV), and red blood cell distribu-
tion width (RDW) are 4.20-6.30 × 10
12/L, 80.0-97.0 fL,
and 11.5-14.5%, respectively. Anemia was defined as
hemoglobin below these lower reference limits (133 g/L,
men; 117 g/L, women) [18]. Thrombocytopenia was
defined as platelet count <140 × 10
9/L; thrombocytosis
was defined as platelet count >440 × 10
9/L. Serum iron
measures were determined using automated clinical
laboratory methods. Total iron-binding capacity (TIBC)
was defined as the sum of serum iron (SI) concentration
and unbound iron-binding capacity. Transferrin satura-
tion (TS) was defined as the quotient of serum iron con-
centration by TIBC. Iron deficiency was defined as both
serum ferritin (SF) <45 pmol/L and TS <10%. Iron deple-
tion was defined as SF <112 pmol/L.
Definition of pica
Pica was defined as the daily compulsive eating of food
or non-food items, singly or in combination, not ordina-
rily part of the patient’s habitual diet or preferences, for
more than one month, and not reasonably attributable
to causes other than iron deficiency by the patient or
treating physician. We tabulated pica food and non-food
items in each case. Most patients were questioned
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deficiency about whether they had pica. Patients whose
charts had no report of pica were classified as not hav-
ing pica.
Observations for tabulation
We compiled these observations at diagnosis in all eligi-
ble patients: age, sex, self-reported race/ethnicity, body
mass index (BMI), and presence (or absence) of pica
reports. We also recorded and categorized symptoms
attributed to iron deficiency or depletion, defined as fati-
gue (fatigue, weakness, decreased stamina); cardiopul-
monary symptoms (shortness of breath, dyspnea on
exertion, palpitations, dizziness, syncope); mental mani-
festations (forgetfulness, slow mentation; difficulty in
performing routine mental tasks); epithelial manifesta-
tions (angular, cheilosis, glossitis, stomatitis, dysphagia,
esophageal web, hair or nail changes, easy bruising); and
neuromuscular symptoms (restless legs syndrome (RLS)
[19], involuntary muscle contractions, paresthesias).
We grouped causes of iron deficiency or depletion
according to these categories: 1) gastrointestinal blood
loss, regardless of lesion(s); 2) reproductive tract loss
(menses and previous pregnancy); 3) medical losses
(laboratory testing, voluntary blood donation, therapeutic
phlebotomy, or surgery); 4) chronic malabsorption (gas-
tric bypass surgery, celiac disease, gastric resection); 5)
urinary tract blood loss (hematuria); 6) recurrent epis-
taxis; and 7) unknown cause. One or two predominant
causes were recorded in each case according to interpre-
tation of the treating physician and our chart review.
We recorded the presence or absence of some other
conditions in each subject because these conditions are
common among patients in our practice: cancer in
remission (any malignancy other than non-melanoma
skin cancer); common variable immunodeficiency
(CVID); diabetes mellitus; and HFE hemochromatosis
associated with C282Y homozygosity. We compiled
values of hemoglobin, RBC, MCV, and RDW; lympho-
cyte, neutrophil, and platelet counts; and SI, TIBC, TS,
and SF levels at diagnosis before intravenous iron dex-
tran therapy was administered.
Pica and recurrent iron depletion or deficiency
In this substudy, we tabulated the presence or absence
of pica detected in patients with recurrent iron defi-
ciency or depletion more than six months after resolu-
tion of clinical and laboratory abnormalities associated
with their respective initial episodes of iron deficiency
or depletion.
Statistical considerations
We reviewed the charts of 267 patients; five cases were
excluded because the chart did not contain all variables
specified for the present analyses. Thus, the analytic
dataset included observations on 262 patients. Continu-
ous variables included age at diagnosis, BMI, CBC
values, and serum iron measures. Dichotomous variables
included sex, race/ethnicity (white vs. black/African
American), presence or absence of pica and other symp-
toms or conditions attributed to iron deficiency or
depletion, causes of iron deficiency or depletion, and
history or no history of cancer in remission, CVID, dia-
betes mellitus, and hemochromatosis. Altogether, there
were 32 variables (pica and 31 others). TIBC values
>86.8 μmol/L were imputed as 87.0 μmol/L; SF values
reported as <4.5 pmol/L were imputed as 2.2 pmol/L.
We analyzed the categories anemia, iron deficiency, iron
depletion, thrombocytosis, thrombocytopenia, and ane-
mia and iron deficiency in univariable but not multivari-
able analyses, because each of these categories is derived
from measured values. Observations analyzed on 18 per-
sons who had recurrent iron depletion or deficiency
included recurrence of pica, CBC values, and serum iron
measures.
Descriptive statistics are displayed as enumerations,
percentages, frequency distribution plots, or mean ± 1
standard deviation (SD). Comparisons were made using
either Student’s two-sided t-test or chi-square or Fisher’s
exact test, as appropriate. We performed stepwise for-
ward multiple logistic regression analyses to identify
independent factors that have a significant positive or
negative association with pica (dependent variable).
Results of the final model are expressed as beta coeffi-
cient, standard error (SE), Wald coefficient/SE, probabil-
ity, and odds ratios (95% confidence interval (CI)). Data
analyses were performed using GB-Stat® v 8.0 (Dynamic
Microsystems, Inc., Silver Spring, MD) and Microsoft
Excel 2000® (Microsoft Corp., Redmond, WA). Values of
p < 0.05 are defined as significant.
Results
General characteristics of study subjects
All patients were treated with intravenous iron dextran
in the interval November 1992-March 2009. There were
230 women (184 white, 46 black) and 32 men (31 white,
1b l a c k ) .T h ea g er a n g eo fw o m e nw a s1 9 - 9 1y e a r s ;t h e
age range of men was 24-81 years (Table 1).
There were reports of pica in 118 patients (45.0%)
(Table 1), and chart documentation of no pica in 49
other cases. Thus, there were explicit reports of pica or
no pica in 63.7% of all 262 cases. Among all 262 sub-
jects, the proportion of women with pica did not differ
significantly from the proportion of men with pica
(47.0% vs. 31.3%, respectively; p = 0.0943). The propor-
tion of whites with reports of pica was lower than the
proportion of blacks with pica (41.1% vs. 61.7%, respec-
tively; p = 0.0113). Among women, the proportion of
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tion of blacks with pica (42.9% vs. 63.0%, respectively;
p = 0.0145).
Fatigue, cardiopulmonary symptoms, and epithelial
manifestations were common among all 262 subjects
(43.9%, 35.5%, and 23.7%, respectively). Gastrointestinal
blood loss occurred in 42.4% and medical blood loss in
11.8% of all subjects; 36.5% of women had reproductive
tract blood loss. Chronic malabsorption occurred in 29
patients (11.2%), 28 of whom (96.6%) were women.
Table 1 Characteristics of 262 adults with iron deficiency or depletion
1
Characteristic White women (184) White men (31) Black women (46) Black men (1)
Age, y 54 ± 16 62 ± 16 42 ± 15 58
Body mass index, kg/m
2 28.9 ± 7.6 29.0 ± 6.3 32.0 ± 9.4 29.6
Pica, % (n) 42.9 (79) 32.3 (10) 63.0 (29) 0
Fatigue, % (n) 41.3 (76) 41.9 (13) 54.3 (25) 100.0 (1)
Cardiopulmonary symptoms, % (n) 28.8 (53) 38.7 (12) 60.9 (28) 0
Epithelial manifestations, % (n) 26.1 (48) 16.1 (5) 19.6 (9) 0
Mental manifestations, % (n) 6.0 (11) 6.5 (2) 0 0
Neuromuscular symptoms, % (n) 4.9 (9) 6.5 (2) 6.5 (3) 0
Gastrointestinal blood loss, % (n) 42.4 (78) 77.4 (24) 17.4 (8) 100.0 (1)
Reproductive blood loss, % (n) 30.4 (56) - 60.9 (28) -
Medical blood loss, % (n) 14.1 (26) 9.7 (3) 4.4 (2) 0
Hematuria, % (n) 1.6 (3) 0 0 0
Epistaxis, % (n) 0 6.5 (2) 0 0
Chronic malabsorption, % (n) 12.0 (22) 3.2 (1) 13.0 (6) 0
Unknown cause of iron deficiency/depletion, % (n) 6.5 (12) 9.7 (3) 8.7 (4) 0
Hemoglobin, g/L 106 ± 19 105 ± 25 93 ± 20 13.6
MCV, fL 79.5 ± 9.9 78.6 ± 8.2 72.5 ± 16.2 81.0
RBC × 10
12/L 4.14 ± 0.63 4.16 ± 0.81 3.93 ± 0.69 5.45
RDW, % 17.3 ± 2.8 18.7 ± 3.5 19.3 ± 4.4 16.8
Platelets × 10
9/L 327 ± 135 264 ± 84 367 ± 125 199
Lymphocytes × 10
9/L 2.0 ± 0.9 1.8 ± 0.9 2.0 ± 0.9 3.7
Neutrophils × 10
9/L 4.5 ± 2.2 4.4 ± 2.0 3.6 ± 1.5 3.4
SI, μmol/L 7 ± 5 7 ± 4 8 ± 6 9
TIBC, μmol/L 74 ± 13 70 ± 14 71 ± 14 60
T S ,% 1 0±7 1 1±8 1 0±6 1 5
SF, pmol/L 29 ± 25 36 ± 25 27 ± 22 58
Cancer in remission, % (n) 11.4 (21) 22.6 (7) 13.0 (6) 100.0 (1)
CVID, % (n) 21.2 (39) 0 0 0
Diabetes mellitus, % (n) 15.2 (28) 19.4 (6) 13.0 (6) 0
Hemochromatosis, % (n) 2.7 (5) 0 0 0
Anemia, % (n) 46.2 (85) 90.3 (28) 93.5 (43) 0
Thrombocytosis, % (n) 14.1 (26) 0 21.7 (10) 0
Thrombocytopenia, % (n) 3.8 (7) 9.7 (3) 0 0
Iron deficiency, % (n) 63.6 (117) 48.4 (15) 69.6 (32) 0
Iron deficiency and anemia, % (n) 46.7 (86) 35.5 (11) 63.0 (29) 0
1Results are expressed as mean ± 1 SD or as percentage (n). Abbreviations: MCV, mean corpuscular volume; RBC, red blood cells; RDW, red blood cell distribution
width; SI, serum iron; TIBC, total iron-binding capacity; TS, transferrin saturation; SF, serum ferritin; CVID, common variable immunodeficiency.
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observed only in white women. Thrombocytosis
occurred only in women (n = 36; 15.6%) (Table 1).
Univariable comparisons of subjects with ice pica
(pagophagia) and non-ice pica
Epithelial manifestations and chronic malabsorption
were less prevalent in 103 patients with pagophagia than
in 15 patients with non-ice pica (Table 2). Mean MCV
and the prevalence of thrombocytosis were lower in
patients with pagophagia than in patients with non-ice
pica. Other characteristics did not differ significantly
between the two patient groups (Table 2).
Univariable comparisons of subjects with and without
pica
Ice was the most common pica item (87.3% of patients
with pica reports) (Table 3). Mean age and the preva-
lence of whites were lower in patients with pica than in
patients without pica. The prevalence of pica reports
was greater in white women aged 19-59 years than in
older women (Figure 1). Cardiopulmonary symptoms
and epithelial manifestations were more common in
patients who reported pica than in those who did not
report pica. Reproductive blood loss was more prevalent
in patients with pica reports than in those without pica
reports (Table 3). All patients with pica reported that
their pica resolved within three weeks (or less) after
administration of their first intravenous infusion of iron
dextran.
Mean hemoglobin and mean MCV values were lower
and mean RDW was higher in patients with reports of
pica with than in patients without reports of pica (Table
3). Mean platelet counts and prevalence of thrombocy-
tosis were higher in patients with reports of pica.
Thrombocytosis occurred only in women and was more
prevalent in those with pica (Table 3). Mean TIBC was
higher and mean SF was lower in patients with pica
reports. The prevalence of iron deficiency, with or with-
out anemia, did not differ significantly between patients
with and without pica reports. The prevalence of cancer
in remission was lower in patients with pica (Table 3).
Five white women were previously diagnosed to have
hemochromatosis, homozygosity for HFE C282Y, and
iron overload phenotypes. They had been treated with
phlebotomy to achieve iron depletion [20]. They subse-
quently developed iron deficiency and associated symp-
toms at ages 34-69 years, 2-11 years after achieving iron
depletion as part of iron overload management. Their
causes of iron deficiency were blood loss at total knee
arthroplasty (n = 2); gastrointestinal bleeding from arter-
iovenous malformations (n = 1); surgery and laboratory
blood loss associated with breast cancer treatment (n = 1);
and chronic iron malabsorption due to gastric bypass
surgery (n = 1). One of these five women reported having
pica (Table 3).
Recurrence of pica
Nineteen patients had recurrent iron deficiency or
depletion. Fifteen had pica at first diagnosis of iron defi-
ciency or depletion (13 white women, 1 white man, 1
black woman); 14 of the fifteen (93.3%) had pica with
recurrent iron deficiency or depletion. Four other
patients (all white women) did not have pica at first
diagnosis; none reported pica with recurrent iron defi-
ciency or depletion. Thus, 94.7% of these patients
retained the same positive or negative pica phenotype
with recurrent iron deficiency or depletion that they had
at first diagnosis. The proportions of patients whose
pica phenotype was the same at the initial and recurrent
episodes of iron deficiency or depletion did not differ
significantly (14/15 vs. 4/4, respectively; p = 0.6213, Chi-
square test). At recurrence of pica, eight of fifteen sub-
jects (53.3%) had hemoglobin and SF levels that were
within the corresponding reference ranges. At recur-
rence of pica, mean MCV was higher and mean RDW
was lower than at first diagnosis of iron deficiency or
depletion; other mean CBC values and serum iron mea-
sures did not differ significantly (Table 4).
Multiple logistic regression analyses
We performed stepwise forward multiple logistic regres-
sions using pica as the dependent variable to determine
the most economical model that would include only sig-
nificant explanatory independent variables. We identi-
fied four significant predictors of pica among the 31
independent variables: age and MCV (negative associa-
tions) and platelet count and RDW (positive associa-
t i o n s )( T a b l e5 ) .N oo t h e rv a riable or combination of
variables added to this four-variable model achieved sta-
tistical significance. The odds ratios and 95% confidence
intervals of the four independent variables associated
with reports of pica are displayed in Table 5.
Discussion
Pica was the most prevalent symptom we observed (45%
of patients). In other studies of adults in the U.S., the
prevalence of pica was 36-61% [8,11,13,14]. In contrast,
pica was reported in only 0.6% of 353 iron-deficient sub-
jects in Japan [15]. Ice craving (pagophagia) was
reported by 87% of the present subjects who reported
pica, consistent with the predominance of pagophagia
among subjects with pica and iron deficiency in other
reports from several countries [1,8,10,11,13,14,16,21,22].
In the present patients with pagophagia, prevalences of
epithelial manifestations, chronic malabsorption, throm-
bocytosis, and mean MCV were lower than in patients
with non-ice pica. It is unknown whether differences in
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1
Characteristic Report of pagophagia (n = 103)
2 Pica without report of ice (n = 15) Value of p
3
Age, y 49 ± 15 52 ± 18 0.5056
Women, % (n) 90.3 (93) 100.0 (15) 0.2421
White, % (n) 74.8 (77) 80.0 (12) 0.4693
Body mass index, kg/m
2 29.7 ± 7.6 30.1 ± 11.2 0.8857
Fatigue, % (n) 45.6 (47) 53.3 (8) 0.5764
Cardiopulmonary symptoms, % (n) 42.7 (44) 46.7 (7) 0.7730
Epithelial manifestations, % (n) 26.2 (27) 53.3 (8) 0.0361
Mental symptoms, % (n) 6.8 (7) 0 (0) 0.3758
Neuromuscular symptoms, % (n) 6.8 (7) 0 (0) 0.3758
Gastrointestinal blood loss, % (n) 36.9 (38) 33.3 (5) 0.7890
Reproductive blood loss, % (n) 43.7 (45) 20.0 (3) 0.0684
Epistaxis, % (n) 0 (0) 0 (0) -
Hematuria, % (n) 1.0 (1) 0 (0) 0.8729
Medical blood loss, % (n) 5.8 (6) 20.0 (3) 0.0877
Chronic malabsorption, % (n) 8.7 (9) 40.0 (6) 0.0007
Unknown cause of iron deficiency/depletion, % (n) 8.7 (9) 6.7 (1) 0.7879
Hemoglobin, g/L 99 ± 21 110 ± 26 0.2471
MCV, fL 73.8 ± 13.1 82.7 ± 8.9 0.0026
RBC × 10
12/L 4.16 ± 0.58 4.11 ± 0.95 0.8764
RDW, % 18.7 ± 3.9 17.7 ± 2.3 0.1637
Platelets × 10
9/L 336 ± 118 464 ± 247 0.0669
Lymphocytes × 10
9/L 1.8 ± 0.8 2.2 ± 0.7 0.1012
Neutrophils × 10
9/L 4.2 ± 2.1 4.8 ± 2.0 0.3587
SI, μmol/L 7 ± 5 7 ± 4 0.8412
TIBC, μmol/L 75 ± 13 77 ± 3 0.5761
TS, % 9 ± 8 9 ± 6 0.8805
SF, pmol/L 27 ± 22 27 ± 5 0.8883
Cancer in remission, % 8.7 (9) 0 (0) 0.2807
CVID, % 9.7 (10) 20.0 (3) 0.2154
Diabetes mellitus, % 13.6 (14) 0 (0) 0.1319
Hemochromatosis, % 1.0 (1) 0 (0) 0.8729
Anemia, % (n) 81.6 (84) 66.7 (10) 0.1808
Thrombocytosis, % (n) 16.5 (17) 46.7 (7) 0.0067
Thrombocytopenia, % (n) 2.9 (3) 6.7 (1) 0.4432
Iron deficiency, % (n) 68.0 (70) 66.7 (10) 0.9201
Iron deficiency with anemia, % (n) 55.3 (57) 40.0 (6) 0.2658
1Results are expressed as mean ± 1 SD or as percentage (n). Abbreviations: MCV, mean corpuscular volume; RBC, red blood cells; RDW, red blood cell distribution
width; SI, serum iron; TIBC, total iron-binding capacity; TS, transferrin saturation; SF, serum ferritin; CVID, common variable immunodeficiency.
2Each of these patients reported pica for ice (pagophagia); some patients reported two or more pica items.
3Comparisons were made using Student’s two-tailed t-test, Chi-square test, or Fisher’s exact test, as appropriate.
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1
Characteristic Report of pica (n = 118)
2 No report of pica (n = 144) Value of p
3
Age, y 50 ± 15 55 ± 17 0.0041
Women, % (n) 91.5 (108) 84.7 (122) 0.0943
White, % (n) 75.4 (89) 87.5 (126) 0.0113
Body mass index, kg/m
2 29.7 ± 8.1 29.3 ± 7.7 0.6667
Fatigue, % (n) 46.6 (55) 41.7 (60) 0.4224
Cardiopulmonary symptoms, % (n) 43.2 (51) 29.2 (42) 0.0180
Epithelial manifestations, % (n) 29.7 (35) 18.8 (7) 0.0387
Mental symptoms, % (n) 5.9 (7) 4.2 (6) 0.5126
Neuromuscular symptoms, % (n) 5.9 (7) 4.9 (7) 0.7013
Gastrointestinal blood loss, % (n) 36.4 (43) 47.2 (68) 0.2411
Reproductive blood loss, % (n) 40.7 (48) 25.0 (36) 0.0068
Epistaxis, % (n) 0 1.4 (2) 0.3011
Hematuria, % (n) 0.8 (1) 1.4 (2) 0.5745
Medical blood loss, % (n) 7.6 (9) 15.3 (22) 0.0564
Chronic malabsorption, % (n) 12.7 (15) 9.7 (14) 0.4429
Unknown cause of iron deficiency/depletion, % (n) 8.5 (10) 6.3 (9) 0.4897
Hemoglobin, g/L 100 ± 22 107 ± 22 0.0251
MCV, fL 75.0 ± 13.0 80.8 ± 9.0 0.0001
RBC × 10
12/L 4.15 ± 0.64 4.08 ± 0.70 0.4232
RDW, % 18.6 ± 3.7 17.2 ± 2.7 0.0006
Platelets × 10
9/L 352 ± 146 305 ± 113 0.0046
Lymphocytes × 10
9/L 1.9 ± 0.7 2.0 ± 1.0 0.4120
Neutrophils × 10
9/L 4.3 ± 2.1 4.3 ± 2.1 0.9327
SI, μmol/L 7 ± 5 8 ± 5 0.1304
TIBC, μmol/L 75 ± 13 72 ± 14 0.0476
TS, % 10 ± 7 11 ± 7 0.1124
SF, pmol/L 27 ± 22 34 ± 25 0.0248
Cancer in remission, % 7.6 (9) 18.1 (26) 0.0136
CVID, % 11.0 (13) 18.1 (26) 0.1113
Diabetes mellitus, % 11.9 (14) 18.1 (26) 0.1657
Hemochromatosis, % 0.8 (1) 2.8 (4) 0.2533
Anemia, % (n) 79.7 (94) 69.4 (100) 0.0605
Thrombocytosis, % (n) 20.4 (24) 8.3 (12) 0.0050
Thrombocytopenia, % (n) 3.4 (4) 4.2 (6) 0.5031
Iron deficiency, % (n) 55.6 (80) 69.5 (82) 0.0720
Iron deficiency with anemia, % (n) 43.8 (63) 54.2 (62) 0.1495
1Results are expressed as mean ± 1 SD or as percentage (n). Abbreviations: MCV, mean corpuscular volume; RBC, red blood cells; RDW, red blood cell distribution
width; SI, serum iron; TIBC, total iron-binding capacity; TS, transferrin saturation; SF, serum ferritin; CVID, common variable immunodeficiency.
2Pica items included: ice (n = 103); ice water (n = 6); salt (n = 4); sugar (n = 3); dirt, soil, or gravel (n = 3); crackers, laundry starch, pickles, or popsicles (2 each);
and candy, cantaloupe, carbohydrates, carbonated beverages, chocolate-covered raisins, coffee beans, dry oatmeal, Gummi® worms, lemons, permanent markers,
popcorn, raw cabbage (and broccoli and spinach), and strawberry ice cream (1 each). Some patients reported two or more pica items.
3Comparisons were made using Student’s two-tailed t-test, Chi-square test, or Fisher’s exact test, as appropriate.
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Page 7 of 11choices of pica items are biologically related to these
manifestations. The number of patients with non-ice
pica was relatively low. Further, studies involving a large
number of comparisons have a high likelihood of finding
statistically significant associations by chance alone
(Type 1 error) [23]. Iron absorption is not significantly
affected by pagophagia [24,25], and thus pagophagia is
an improbable cause of iron deficiency or depletion.
The proportions of women and men who reported
pica did not differ significantly. In two other studies, the
prevalence of pica was significantly greater in women
than men with iron deficiency [8,14]. In the present
women, however, the proportion of whites with pica
was significantly lower than that of blacks with pica. In
a series of iron deficiency cases from South Africa, there
was no significant difference in the prevalence of pica
between whites and blacks [10]. We observed that the
prevalence of epithelial manifestations was greater in
patients with pica reports. In another study, diagnoses
of fibromyalgia were significantly more prevalent in
iron-deficient subjects with pica than in those without
pica [26].
Pica was not significantly associated with the cause(s)
of blood loss or iron deficiency or depletion in the pre-
sent study. This is consistent with previous reports of
pica in adults with iron deficiency due to menorrhagia
or pregnancy [14]; gastrointestinal blood loss [14]; thera-
peutic phlebotomy for polycythemia rubra vera [27]; and
malabsorption of iron due to gastric bypass [28,29]. Pica
is not a predictor of the cause of gastrointestinal blood
loss in persons with iron deficiency [14]. Although
infection of the stomach with Helicobacter pylori was
0
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Figure 1 Frequency distribution plot of percentages of white women with pica and iron deficiency or depletion. The prevalence of pica
reports was greater in women aged 19-59 years than in older women (55.9% vs. 34.8%; p = 0.0061).
Table 4 Characteristics of 14 patients with recurrent
pica
1
Characteristic First diagnosis Recurrence Value of p
2
Hemoglobin, g/dL 108 ± 16 122 ± 18 0.0500
MCV, fL 75.2 ± 9.9 81.9 ± 7.0 0.0493
RBC × 10
12/L 4.44 ± 0.48 4.55 ± 0.50 0.5786
RDW, % 18.7 ± 3.2 16.1 ± 2.3 0.0240
Platelets × 10
9/L 335 ± 87 311 ± 86 0.4901
Lymphocytes × 10
9/L 1.8 ± 0.7 2.0 ± 0.7 0.3808
Neutrophils × 10
9/L 4.3 ± 2.0 4.0 ± 1.7 0.6368
SI, μmol/L 7 ± 4 8 ± 4 0.8523
TIBC, μmol/L 75 ± 14 69 ± 8 0.2517
TS, % 8 ± 5 12 ± 6 0.1721
SF, pmol/L 27 ± 22 83 ± 108 0.0824
1Each patient had pica at first diagnosis of and at recurrence of iron
deficiency or depletion. Data are presented as mean ± 1 SD. Abbreviations:
MCV, mean corpuscular volume; RBC, red blood cells; RDW, red blood cell
distribution width; SI, serum iron; TIBC, total iron-binding capacity; TS,
transferrin saturation; SF, serum ferritin.
2Comparisons of mean values at first diagnosis and at recurrence of iron
deficiency or depletion were made using Student’s two-tailed t-test.
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Page 8 of 11associated with autoimmune gastritis and iron deficiency
in men [8,30], there was no significant association of
pica with H. pylori infection in adults with iron defi-
ciency [25].
Mean hemoglobin levels were significantly lower in
the present patients with pica than in those without
pica. The prevalence of anemia, iron deficiency, or iron
deficiency with anemia did not differ significantly
between these two groups. Patients with pica had signifi-
cantly lower mean values of MCV and significantly
higher mean RDW and mean platelet counts than
patients without pica. Thrombocytosis was observed
only in women with pica, consistent with a previous
report of platelet counts in adults with iron deficiency
[31,32]. In normal control subjects, mean platelet counts
are also significantly higher in women than men [33]. In
the present analyses, mean values of TIBC and SF were
significantly lower in patients with pica than in patients
without pica, but the magnitude of these respective dif-
ferences was small.
F i v ew h i t ew o m e ni nt h ep r e s e n ts t u d yw e r ep r e -
viously diagnosed to have hemochromatosis with homo-
zygosity for HFE C282Y and were treated with
phlebotomy to achieve iron depletion [20]. Later, they
developed iron deficiency due to causes unrelated to
therapeutic phlebotomy, like some other patients diag-
nosed to have HFE hemochromatosis in medical care or
population screening [34-37]. The proportion of patients
with reports of pica who had cancer in remission was
lower than the proportion of patients without pica who
had cancer in remission. In 55 unselected patients with
iron-deficiency anemia due to gastrointestinal blood loss
evaluated by a gastroenterology referral service at a city
hospital, the proportion of patients with malignancy
who had pica was significantly lower than the propor-
tion of patients without malignancy (2/9 vs. 30/46;
p = 0.0217; Fisher’s exact test) [14].
Using multiple logistic regression analyses, we identi-
fied four significant predictors of pica among 31 inde-
pendent variables: age and MCV (negative associations)
and platelet count and RDW (positive associations).
Regardless, the odds ratios associated with these
variables were relatively low. Only age represents a con-
dition that existed before the development of iron deple-
tion or deficiency in our series of 262 non-pregnant
adults. In a French study, age and sex were not signifi-
cant predictors of pica in a multiple logistic regression
model of observations from 79 patients with iron defi-
ciency, although 40% of them were pregnant women [9].
The other “pre-existing” factors that were significant in
our univariable comparisons (sex, race/ethnicity, cancer
in remission, CVID, diabetes mellitus, and hemochroma-
tosis) were not significant independent predictors of
pica in multiple logistic regression analyses. These
observations suggest that pica is triggered by factors
that precede routine diagnostic indicators of iron deple-
tion or deficiency such as abnormal CBC values or
serum iron measures, or structural changes in the
epithelial surfaces of the lips, oral cavity, and nasophar-
ynx [38-42].
The present results confirm that pica develops in
some adults with iron depletion or iron deficiency and
not in others [8,11,13-15], although the reason(s) for
this dichotomy is not reported. The concordance of
recurrent pica (or absence of pica) in 19 of present
patients who developed a second episode of iron defi-
ciency or depletion was high (95%). Further, pica
recurred in some of the present patients before they
developed anemia or hypoferritinemia. In another study,
pica was also a relatively early indicator of recurrent
iron deficiency or depletion in patients who had under-
gone gastric bypass surgery [17]. Other investigators
have reported that the occurrence of pica is not necessa-
rily related to the severity of iron deficiency [43].
Thrombopoiesis may be stimulated by early iron deple-
tion [44,45]. Pica in the present patients resolved rapidly
after administration of intravenous iron dextran, in
agreement with previous reports [4,11,12]. A genetic
predisposition to develop pica in the presence of iron
deficiency or depletion could explain these observations.
Some reports including the present one suggest that
certain manifestations of iron deficiency are affected by
heritable traits. TMPRSS6 (OMIM *609862; chromo-
some 22q12-q13) encodes matripase-2 (transmembrane
Table 5 Significant predictors of pica in a logistic regression model
1
Variable Beta
coefficient
Standard error
(SE)
Wald
Coefficient/SE
Probability Odds ratio (exponential
beta)
95% Confidence interval of odds
ratio
age, y -0.190 0.009 -2.242 0.025 0.981 (0.965, 0.998)
MCV, fL -0.024 0.008 -3.119 0.002 0.977 (0.962, 0.991)
RDW, % 0.105 0.032 3.328 0.001 1.111 (1.044, 1.182)
Platelets ×
10
9/L
0.002 0.001 2.288 0.022 1.002 (1.000, 1.004)
1These results, obtained in a forward stepwise logistic regression model, include only the significant independent predictors of pica occurrence. Abbreviations:
MCV, mean corpuscular volume; RDW, red blood cell distribution width. Significance of this regression: Chi-square (4 degrees of freedom) = 30.42; probability
<0.0001.
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Page 9 of 11serine protease 6). The TMPRSS6 allele A736V (rs855791)
was related to significantly lower levels of SI, TS, MCV,
and hemoglobin in two genome-wide association studies
of twins and general population subjects, respectively
[46,47]. TMPRSS6 A736V could explain the small but
significant differences we observed in mean MCV and
hemoglobin levels in patients with and without pica
reports, although this is unproven. RLS also occurs as an
acquired manifestation of iron deficiency [19,48-50], and is
cured by reconstitution of iron stores [51].
Pica ascertainment is an uncertainty in the present
study. There was no ascertainment of pica based on
chart review in 36.3% of the present cases; patients
whose charts had no report of pica were classified as
not having pica. Nonetheless, iron depletion or defi-
ciency in all 262 patients in this study was diagnosed
and managed by the same two clinicians (JCB and LFB).
Accordingly, the likelihood that a distinctive symptom
such as pica was not recorded in our medical records,
had it occurred, is small. It was beyond the scope of the
present study to attempt to contact patients without
documented ascertainment of pica for further interview
on this point. Uncertainties of our study also include
the possibility that some patients did not report pica
because they were forgetful or embarrassed [6].
Although the present patients were not treated with oral
iron supplements, the proportions of present patients
with pica and other manifestations of iron deficiency or
depletion are similar to those in reports from North
America in which oral iron supplementation was used
[8,11,13,14]. Our case series included only one black
man, prohibiting us from making conclusions about pica
in black men. Medications such as aspirin, non-steroidal
anti-inflammatory drugs, and warfarin may increase the
loss of blood (and thus iron) from the gastrointestinal
tract [52-57]. Other medications, including proton
pump inhibitors, histamine receptor-2 antagonists, and
preparations that contain calcium, may decrease iron
absorption in short-term studies [58-61]. Although we
did not tabulate these medications for analysis, other
v a r i a b l e ss u c ha sb l o o dl o s sf r o md i f f e r e n ts i t e so r
chronic malabsorption were not significantly associated
with increased prevalence of pica.
Conclusions
In non-pregnant adult patients with iron deficiency or
depletion, lower age is a significant predictor of pica.
Patients with pica have lower MCV, higher RDW, and
higher platelet counts than patients without pica.
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